GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SRTOY) » Definitions » Cyclically Adjusted PB Ratio

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Cyclically Adjusted PB Ratio : 12.26 (As of May. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Sartorius Stedim Biotech Cyclically Adjusted PB Ratio?

As of today (2024-05-25), Sartorius Stedim Biotech's current share price is $20.72. Sartorius Stedim Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $1.69. Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio for today is 12.26.

The historical rank and industry rank for Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio or its related term are showing as below:

SRTOY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 11.68   Med: 19.69   Max: 37.1
Current: 13.34

During the past years, Sartorius Stedim Biotech's highest Cyclically Adjusted PB Ratio was 37.10. The lowest was 11.68. And the median was 19.69.

SRTOY's Cyclically Adjusted PB Ratio is ranked worse than
95.33% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs SRTOY: 13.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted book value per share data for the three months ended in Dec. 2023 was $3.121. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.69 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 25.02 16.24

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.02 21.73 17.01 15.95 16.24

Competitive Comparison of Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio falls into.



Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=20.72/1.69
=12.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sartorius Stedim Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.121/123.7729*123.7729
=3.121

Current CPI (Dec. 2023) = 123.7729.

Sartorius Stedim Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201012 0.473 94.132 0.622
201106 0.524 95.158 0.682
201112 0.564 95.998 0.727
201206 0.553 96.744 0.708
201212 0.555 97.957 0.701
201306 0.580 98.516 0.729
201312 0.641 99.356 0.799
201406 0.648 99.543 0.806
201412 0.712 99.543 0.885
201506 0.709 100.417 0.874
201512 0.758 99.717 0.941
201606 0.818 100.717 1.005
201612 0.867 101.217 1.060
201706 0.971 102.117 1.177
201709 0.000 102.717 0.000
201712 1.120 102.617 1.351
201803 0.000 102.917 0.000
201806 1.163 104.017 1.384
201809 1.225 104.718 1.448
201812 1.279 104.217 1.519
201903 1.283 104.217 1.524
201906 1.347 105.718 1.577
201909 1.395 106.018 1.629
201912 1.397 105.818 1.634
202003 1.471 105.718 1.722
202006 1.538 106.618 1.785
202009 1.721 105.818 2.013
202012 1.898 105.518 2.226
202103 1.977 107.518 2.276
202106 2.181 108.486 2.488
202109 2.129 109.435 2.408
202112 2.030 110.384 2.276
202203 2.298 113.968 2.496
202206 2.353 115.760 2.516
202209 2.442 118.818 2.544
202212 2.815 119.345 2.919
202303 2.812 122.402 2.843
202306 3.020 123.140 3.036
202309 3.005 124.195 2.995
202312 3.121 123.773 3.121

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius Stedim Biotech  (OTCPK:SRTOY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.